Chinese Oncology Drug Developer Tot Biopharm Raises $75.2m In HK IPO

Business - Published date: Friday November 08, 2019.

Tot Biopharm, a Chinese clinical-stage biopharma firm specialized in innovative oncology drugs and therapies, has raise... Read more